Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pfizer Likes Consumer Business Right Where It Is, Or Eventually Could Be

This article was originally published in The Tan Sheet

Executive Summary

Driven by US sales of Nexium 24HR and Advil, Pfizer's fiscal 2016 first-quarter consumer product revenues increased 2% to $822m. CEO Ian Read says Pfizer is open to adding to or selling off its consumer business, but currently likes it just where it is.

Advertisement

Related Content

Pfizer Keeps Hands On Consumer Product Wheel In Opting Against Split
Pfizer's OTC, Nutritional Businesses Could Be Looking For A New Home

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register